Skip to main content

New top story from Time: FDA Panel Greenlights First Single-Shot COVID-19 Vaccine, from Johnson & Johnson

https://ift.tt/3pZf3dk

The U.S. Food and Drug Administration’s (FDA) vaccine advisory committee earlier today (Feb. 26) voted unanimously to recommend Johnson & Johnson’s COVID-19 vaccine for emergency use authorization. While the FDA isn’t obligated to follow the committee’s advice, it generally does.

At the end of a full day of review and discussion of the company’s shot, all 22 voting members of the committee agreed that the vaccine was safe and effective enough to be used by the public. It’s the third vaccine that the group of independent experts has recommended, following Pfizer-BioNTech and Moderna. Unlike the two previous vaccines, J&J’s is a single shot, and can be shipped and stored under refrigerated, not frozen conditions, as the other two require.

The single dosing played a part in the committee’s decision. Logistically, vaccinating people one time is much easier than asking them to return for a second dose. “This was a relatively easy call,” Dr. Eric Rubin, editor in chief of the New England Journal of Medicine and professor at Harvard T.H. Chan School of Public Health, who voted to recommend the shot said during the discussion. “[The vaccine] clearly gets way over the bar of safety and efficacy, and it’s a single-dose vaccine.”

The committee members reviewed data presented by Janssen Pharmaceuticals, the J&J arm that developed the vaccine, as well as FDA scientists’ review of that data. Janssen’s vaccine uses a different technology than Pfizer-BioNTech and Moderna, which both relied on a new platform involving mRNA. Janssen’s vaccine, on the other hand, is made with a weakened cold virus that can’t cause disease, manipulated so that it carries the genes for making one of the key proteins of SARS-CoV-2, the virus that causes COVID-19. Once that viral protein is introduced to the body, human immune cells learn to recognize it as foreign and launch attacks against it.

In Janssen’s primary vaccine study, involving nearly 44,000 people, a single dose was found to be 66% effective in protecting people from moderate to severe COVID-19 disease. It was slightly less effective in protecting against new variants of the virus—against one that was first identified in South Africa, it was around 57%. Still, that protection met the threshold of 50% efficacy set by the FDA for granting emergency use authorization.

Committee members raised questions about how much of the immune response to the COVID-19 virus might be blunted by a response mounted against the weakened cold virus used as the delivery vessel, a well known effect using this vaccine platform. Such vaccines are also potentially less effective when boosted with additional shots since the body becomes tolerant to the weakened virus vector. However, Dr. Johan Van Hoof, managing director of Janssen Vaccines and Prevention, noted that tests on the company’s HIV vaccine candidate using similar technology have shown that people boosted with additional shots years after the first continued to generate strong immune responses that didn’t seem to be significantly affected by the weakened virus vector.

Many committee members raised questions about the company’s data showing that the vaccine produced a slightly lower response in terms of antibody levels against the virus among people over age 60, especially those with underlying health conditions—a group particularly vulnerable to COVID-19. However, Janssen studies found that these people still did not develop severe COVID-19 disease or need hospitalization compared to people getting placebo. In fact, the vaccine was 85% effective in protecting people from severe disease and overall there were only 21 deaths among the 44,000 people studied; five occurring among those who were vaccinated and the remainder among the placebo group. None of the deaths were considered related to the vaccine.

The FDA scientists did note in their review that some participants in the study did experience serious side effects, including tinnitus (ringing in the ears), clotting and hives—which could be related to the vaccine and are worth further follow up. However, these were rare, and overall the vaccine was safe with most who reported side effects having only mild to moderate reactions including headache, chills and muscle aches.

The other question that continued to pop up during the day-long discussion focused on whether Janssen’s vaccine is really a one-shot vaccine or whether it, like the Pfizer-BioNTech and Moderna vaccines, actually requires a two-shot regimen. While the data the company submitted were from a trial in which participants were given only a single dose, the company is currently conducting another study of 30,000 people who will receive two doses of the shot—to see if an additional booster will raise immune responses even further.

If two doses prove to be more effective, it will raise a tricky question about what to do with people who might receive the single dose shot in coming weeks or months, should the one-dose regimen be authorized. Van Hoof argues that this is a question worth putting off for later, given the urgency of the current situation. “We feel the results of the study of our single dose showed high efficacy against severe disease, especially hospitalizations and death, and in a situation of mass vaccination programs, our regimen is extremely well positioned to be used during the outbreak,” he said.

Then of course there is the question of the recently identified genetic variants of SARS-CoV-2 that appear even more infectious than the original virus. Pfizer-BioNTech and Moderna did not have to deal with that when they submitted their requests back in December 2020, but the companies have since conducted additional tests that have shown that their vaccines remain effective in protecting against the major new mutations. Janssen’s submission to the FDA included some early data on the efficacy of its vaccine against the new variants, and Van Hoof told the committee that the company plans to continue genetic sequencing virus from people in the company’s trials if they test positive and will include that information in the final request for full approval which could come later this year. In the meanwhile, Janssen—like Pfizer-BioNtech and Moderna—is already working on a next-generation vaccine specifically targeting the new variants that could begin human testing by summer.

The FDA committee’s decision to recommend the Janssen shot now goes to the agency. If the FDA agrees to grant the emergency use authorization, the next step will be for the Centers for Disease Control and Prevention’s immunization committee to work out details of who should be vaccinated with the new shot, and the logistics for how to make that happen. That CDC committee will also likely make decisions about whether certain groups should be targeted to receive this specific vaccine, and what advice to provide vaccinators when people ask about whether they will need a second shot. That information won’t be available until Janssen completes its two-dose study in coming months.

Comments

Popular posts from this blog

New T Third Connecting Chinatown to Sunnydale Starts Saturday

New T Third Connecting Chinatown to Sunnydale Starts Saturday By Christopher Ward New Muni Metro map. This Saturday the T Third starts its long-awaited new route connecting Chinatown-Rose Pak Station from 4th & King in Central Subway, Mondays through Fridays, 6 a.m. to midnight every 10 minutes and Saturdays and Sundays, 8 a.m. to midnight every 12 minutes.   The K Ingleside will now travel between Balboa Park and Embarcadero Station. Customers using Embarcadero & Folsom, Embarcadero & Brannan and 2nd and King platforms should transfer to the N Judah at Powell Station or 4th & King. Watch the new Muni Metro service  map animations . The following bus service changes also start this Saturday: The T Third Bus will now run along 3rd and 4th Streets in SoMa and on Stockton Street north of Market Street to align with the new T Third rail line and will no longer travel on the Embarcadero and Market Street.   The 6 Haight/Parnassus  will now...

New top story from Time: New York Prosecutor Convenes Grand Jury in Criminal Investigation of Donald Trump

https://ift.tt/3wuXF3R (NEW YORK) — New York prosecutors have convened a special grand jury to consider evidence in a criminal investigation into former President Donald Trump’s business dealings, a person familiar with the matter told The Associated Press on Tuesday. The development signals that the Manhattan district attorney’s office was moving toward seeking charges as a result of its two-year investigation, which included a lengthy legal battle to obtain Trump’s tax records. The person familiar with the matter was not authorized to speak publicly and did so on condition of anonymity. The news was first reported by The Washington Post . Manhattan District Attorney Cyrus Vance Jr. is conducting a wide-ranging investigation into a variety of matters such as hush-money payments paid to women on Trump’s behalf, property valuations and employee compensation. The Democratic prosecutor has been using an investigative grand jury through the course of his probe to issue sub...

Residents Overwhelmingly Support Slow Streets

Residents Overwhelmingly Support Slow Streets By Eillie Anzilotti After over a year of Slow Streets providing safe, low-volume corridors for people to walk, bike, play and travel during the pandemic, we’re excited to share our first comprehensive evaluation of the program . The key takeaway? San Franciscans are overwhelmingly in support of Slow Streets. Slow Streets are designed to limit through traffic on certain residential streets and allow them to be used as a shared roadway for people traveling by foot and by bicycle. Since introducing Slow Streets in April 2020 in response to the Mayor’s Emergency Health Order, SFMTA has designated around 30 corridors covering 47 miles of roadway as Slow Streets. The program has evolved from a critical component of San Francisco’s pandemic response and recovery to a potential new avenue to further the city and SFMTA’s goals around climate action and sustainable transportation. As the Slow Streets program has grown, we wanted to make sure we...

Transit Lanes Keep Muni Moving on Mission Street in SoMa

Transit Lanes Keep Muni Moving on Mission Street in SoMa By Erin McMillan The full-time transit lanes on Mission Street downtown installed as a temporary emergency measure during the pandemic will be made permanent. The first of the city’s Temporary Emergency Transit Lanes to get permanent authorization, they were unanimously approved by the SFMTA Board of Directors at their June 15, 2021 meeting. This shows how a quick-build project can be installed, evaluated, and refined in a relatively short amount of time.   Thousands of daily riders have already felt the impact of the full-time transit lanes since they were first temporarily installed last summer. Now, riders of the 14 Mission, 14R Mission Rapid, and many SamTrans and Golden Gate Transit customers will continue to benefit from the transit time savings we have seen with the implementation of these lanes. Mission Street in SoMa has been a major transit corridor for years, serving regional commuter...

FOX NEWS: What is TikTok's 'Check Your Privilege' challenge?

What is TikTok's 'Check Your Privilege' challenge? Activists are calling for awareness and change following the death of George Floyd. via FOX NEWS https://ift.tt/3crYd00

New Sculptures Light up Van Ness Avenue

New Sculptures Light up Van Ness Avenue By Luis “Loui” Apolonio Light sculpture at Van Ness Avenue and O'Farrell Street Spectators gathered both online and in person to watch new lighting sculptures on Van Ness turned on for the first time on March 31, 2022. The whimsical and brightly colored sculptures located on the new Van Ness BRT boarding platform between Geary and O’Farrell are made of steel with LED lights inside on a timer set to illuminate at night.  The lighting event was kicked off with SFMTA Director Jeff Tumlin and MTAB Chair Gwyneth Borden serving as emcees. Mary Chou, Director of Public Arts and Collections at the San Francisco Arts Commission, spoke about the art installation itself, as well as the process for selecting the artist who would be awarded the project. In addition, Maddy Ruvolo, a member of the SFMTA’s Accessible Services team and a recently appointed member of President Biden’s U.S. Access Board, shared the importance of having accessibility as a ...

New Muni Service Changes Start Saturday, August 19

New Muni Service Changes Start Saturday, August 19 By Clive Tsuma 28R 19th Avenue will run on weekdays between 7 a.m. and 7 p.m. starting Monday, August 21.  Back to School  With SFUSD students returning to school August 16, many families who rely on Muni to get to school will see service increase after school as part of the new schedule. Because Muni vehicles often become crowded during morning peak hours and sometimes pass up stops when there is not enough room for more riders, families are encouraged to plan their trips ahead of time and hop on Muni early to make sure students get to school on time.  With every public school in the San Francisco Unified School District being served by at least one Muni route , students can expect extra Muni service on the first day of the school this fall and continue providing service throughout the school year. While the Muni service changes won’t be implemented until August 19, school tripper service will be offered starting Au...

New top story from Time: A Photographer’s Journey Through the Dangerous New Age of Conspiracies in America

https://ift.tt/354JVAF In November 2017, the House Intelligence Committee released fake advertisements found on Facebook in the walk up to the 2016 election. As politicians on each side argued over whether the ads changed the election results, the heart of the revelation was way more disturbing. The Russian ads targeted the American public to deepen wounds on divisive issues and spread false information. Facebook said the posts were “ what we saw from these actors was an insidious attempt to drive people apart ,” according to Colin Stretch, the general counsel for the company. In 2020, less than one month before the election, America seems even more divided and deeply fractured after a turbulent year with a deadly pandemic, economic pain, and a chaotic presidency. With many Americans on lockdown, social media has been a vital form of communication — but one that is also driving dangerous conspiracies. From the false QAnon conspiracy, which promotes Trump as the final de...

New top story from Time: WikiLeaks Founder Julian Assange Accused of Conspiring With LulzSec and Anonymous Hackers

https://ift.tt/3hZ0cN4 WikiLeaks founder Julian Assange conspired with hackers affiliated with the “Anonymous” and “LulzSec” groups, which have been linked to numerous cyber attacks around the world, according to new indictment by the U.S. Justice Department. Assange, who’s detained in the U.K. on a U.S. extradition request, gave the leader of LulzSec a list of targets to hack in 2012 and told this person that the most influential release of hacked materials would be from the Central Intelligence Agency, National Security Agency or the New York Times, according to a statement Wednesday from the Justice Department. The LulzSec leader was cooperating with the Federal Bureau of Investigation at the time, according to the statement. An Anonymous and LulzSec-affiliated hacker stole emails through a data breach of an American intelligence consulting company that were published in WikiLeaks, according to the statement. Assange indirectly asked that hacker to spam that company a...

Powered Scooters Charge City’s Transportation Recovery

Powered Scooters Charge City’s Transportation Recovery By Jason Hyde The SFMTA is releasing its next round of Powered Scooter Share permits on July 1. Scooters remain a sustainable mode of travel and a complement to Muni and public transit service as the city recovers from the pandemic and San Franciscans begin to travel more. The SFMTA’s Powered Scooter Share Program is essential in ensuring that shared scooter operations support the city’s economic recovery in a safe, sustainable, and equitable way.  The SFMTA received four submittals for the permit program and will issue permits to two operators : Spin and Lime. Permits will be in effect for a one-year term, with the option to extend for another year at the discretion of the SFMTA based on compliance with various program metrics. While the new permit program does not set a limit on the number of scooters each operator may deploy, it does limit the overall citywide fleet size at 10,000. Starting at a base of 2,000 scooters...